Matinas BioPharma Holdings (MTNB) Net Cash Flow (QoQ) (2013 - 2026)
Matinas BioPharma Holdings (MTNB) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.49% |
| Dec 31, 2025 | -1.84% |
| Sep 30, 2025 | -253.38% |
| Jun 30, 2025 | -10.83% |
| Mar 31, 2025 | 88.04% |
| Dec 31, 2024 | -149.53% |
| Sep 30, 2024 | 93.29% |
| Jun 30, 2024 | 184.63% |
| Mar 31, 2024 | -129.38% |
| Dec 31, 2023 | 51.44% |
| Sep 30, 2023 | -183.32% |
| Jun 30, 2023 | 467.00% |
| Mar 31, 2023 | 74.90% |
| Dec 31, 2022 | -659.33% |
| Sep 30, 2022 | 108.70% |
| Jun 30, 2022 | -424.62% |
| Mar 31, 2022 | 56.27% |
| Dec 31, 2021 | 29.43% |
| Sep 30, 2021 | -179.14% |
| Jun 30, 2021 | -36.35% |